个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Retraction: Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity

| 认领 | 导出 | |

文献详情

资源类型：
Pubmed体系：
作者：
Jiang Yueqiang[1] * ; Ma Yanling[2] ; Li RuiChao[1] ; Sun JianHai[2] ;
单位： [1]Department of Gerontology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China. [2]Department of Oncology, the Third People's Hospital, Wuhan, Hubei Province, China.
出处：
DOI： 10.18632/oncotarget.28325
语种：
外文
PubmedID：
第一作者：
第一作者单位： [1]Department of Gerontology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
推荐引用方式(GB/T 7714)：
Jiang Yueqiang,Ma Yanling,Li RuiChao,et al.Retraction: Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity[J].Oncotarget.2022,13:1322.doi:10.18632/oncotarget.28325.
APA：
Jiang Yueqiang,Ma Yanling,Li RuiChao&Sun JianHai.(2022).Retraction: Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity.Oncotarget,13,
MLA：
Jiang Yueqiang,et al."Retraction: Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity".Oncotarget 13.(2022):1322

资源点击量：590 今日访问量：1 总访问量：442 更新日期：2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）